- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05492253
First Complementary Foods and the Infant Gastrointestinal Microbiota
May 15, 2024 updated by: Jill Trabulsi, University of Delaware
Effect of First Complementary Foods on the Infant Gastrointestinal Microbiota: A Pilot Study
This study evaluates the effect of different complementary foods on the gastrointestinal microbiota of exclusively human milk fed infants.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The introduction of solid foods plays a role in shaping the microbial communities of the gastrointestinal microbiota.
This randomized, controlled, single-blinded trial will evaluate the effect of four infant foods (oatmeal cereal, carrot puree, prune puree, beef and gravy puree) on the gastrointestinal microbiota of exclusively human milk fed infants that have not previously consumed solid foods and who are developmentally ready for the introduction of solid foods.
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- University of Delaware
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 7 months (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Infant was born vaginally
- Infant was born full term
- Infant has no significant gastrointestinal medical issues/diagnoses (e.g., gastroesophageal reflux, malabsorption syndromes, Celiac disease, Crohn's disease, or physician diagnosed or suspected food allergies)
- Infant is at least 5 months old, but not 8 or more months old
- Infant consumes an exclusively human milk liquid diet only
- Infant has not yet begun consuming solid foods
- Infant is developmentally ready to begin consuming solid foods (i.e., has good head and neck control, can sit upright when supported, and has at least doubled their birth weight)
- Infant has not had antibiotics within the past month
- Infant's nursing mother has not had antibiotics within the past month
- Parent/legal guardian is at least 18 years old
Exclusion Criteria:
- Infant is not developmentally ready to begin solid foods
- Infant has a family history of food allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Infant cereal
Oatmeal cereal
|
Infants will be fed oatmeal cereal
|
|
Experimental: Infant fruit
Pureed prunes
|
Infants will be fed prune puree
|
|
Experimental: Infant vegetable
Pureed carrots
|
Infants will be fed carrot puree
|
|
Experimental: Infant meat
Pureed beef
|
Infants will be fed beef puree
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in gastrointestinal microbiota
Time Frame: Day 0, 3, 7, 10, 14
|
Composition of the gastrointestinal microbiota (family, genus, and species levels via shotgun metagenomic sequencing) before and after the introduction of solid food
|
Day 0, 3, 7, 10, 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jillian Trabulsi, PhD, RD, University of Delaware
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2023
Primary Completion (Actual)
March 12, 2024
Study Completion (Actual)
March 12, 2024
Study Registration Dates
First Submitted
July 26, 2022
First Submitted That Met QC Criteria
August 4, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
May 17, 2024
Last Update Submitted That Met QC Criteria
May 15, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 1889964-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Touro University, CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy Participants | Obese But Otherwise Healthy ParticipantsUnited States
-
Beijing Tide Pharmaceutical Co., LtdRecruitingHealthy | Healthy ParticipantsChina
-
Aston UniversityCooperVision, Inc.Enrolling by invitationHealthy | Healthy ParticipantsUnited Kingdom
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Standard Process Inc.Recruiting
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
Hoffmann-La RocheNot yet recruiting
-
Simcere Pharmaceutical Co., LtdNot yet recruiting
Clinical Trials on Infant grain
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
Purdue UniversityGrain Foods FoundationRecruitingHigh Whole Grain and Low Sugar | Medium Whole Grain and Low Sugar | Low Whole Grain and Low Sugar | Low Whole Grain and High SugarUnited States
-
USDA Beltsville Human Nutrition Research CenterUnited States Department of Agriculture (USDA)Completed
-
University of MinnesotaCompleted
-
University of CopenhagenTechnical University of DenmarkUnknownMetabolic Disease | Injury of Gastrointestinal TractDenmark
-
University of FloridaGeneral MillsCompleted
-
University of Illinois at Urbana-ChampaignRecruitingCardiovascular Diseases | Dysbiosis | Gastrointestinal Dysfunction | Nutritional and Metabolic DiseasesUnited States
-
Cereal Partners WorldwideCompleted
-
King's College LondonCompleted
-
University of Wisconsin, MadisonPepsiCo, Inc.; CIMMYTCompletedβ-cryptoxanthin Bioavailability From Biofortified Maize in HumansUnited States